AMA in Action: Ending the overdose epidemic
UPDATED
·
4 Min Read

Advocacy in action: Ending the overdose epidemic

Science, evidence and compassion must guide patient care and policy change to end the drug-overdose epidemic.

Behavioral Health
·
4 Min Read

Top news stories from AMA Morning Rounds®: Week of May 29, 2023

In the news: Eligible Americans lose Medicaid coverage, impact of exercise on brain health, FDA issues warning on off-brand semaglutide and more.

Publications & Newsletters
·
12 Min Read

Cannabis side effects for senior and older adult patients with Alison Moore, MD, MPH

The AMA Update covers a range of health care topics affecting the lives of physicians and patients. Learn more about the risks of cannabis for seniors.

series
Behavioral Health
AMA Update
·
12 Min Read

Cannabis side effects for senior and older adult patients with Alison Moore, MD, MPH [Podcast]

The AMA Update covers a range of health care topics affecting the lives of physicians and patients. Learn more about the risks of cannabis for seniors.

series
Behavioral Health
AMA Update Podcast
·
5 Min Read

Top news stories from AMA Morning Rounds®: Week of May 22, 2023

In the news: Benefits of semaglutide, surgeon general warns of social media risks, implants help paralyzed man walk, key long COVID symptoms identified and more.

Publications & Newsletters
·
10 Min Read

May 19, 2023: National Advocacy Update

 Senate Committee passes bipartisan PBM legislation and more in the latest National Advocacy Update.

Advocacy Update
Narcan nasal spray
·
4 Min Read

Narcan lands OTC approval: What it means for patients, doctors

The drug’s manufacturer and retailers must help ensure the lifesaving opioid overdose-reversal medication is widely available at an affordable price. 

Behavioral Health
·
1 Min Read

AMA statement on DEA extending telehealth prescription flexibilities

The AMA applauds the DEA extending flexibilities in the prescribing of controlled substances through telehealth visits through Nov. 11, 2023.

Press Releases
·
4 Min Read

Top news stories from AMA Morning Rounds®: Week of April 24, 2023

In the news: SCOTUS action on mifepristone, shift in Alzheimer’s treatment, mislabeling of melatonin gummies, cigarette smoking at all-time low and more.

Publications & Newsletters